Forward looking statements
Search documents
American Strategic Investment (NYC) - 2025 Q1 - Earnings Call Transcript
2025-05-09 16:00
Financial Data and Key Metrics Changes - First quarter 2025 revenue was $12.3 million, down from $15.5 million in the first quarter of 2024, primarily due to the sale of Nine Times Square in Q4 2024 [11] - GAAP net loss attributable to common stockholders was $8.6 million in Q1 2025, compared to a net loss of $7.6 million in Q1 2024 [11] - Adjusted EBITDA for Q1 2025 was negative $800,000, down from $2.9 million in Q1 2024 [11] - Cash net operating income was $4.2 million in Q1 2025, compared to $7 million in Q1 2024 [11] - At quarter end, net leverage was approximately 58%, with a weighted average interest rate of 4.4% and a weighted average debt maturity of 2.3 years [12] Business Line Data and Key Metrics Changes - The company focused on leasing available space and extending leases, achieving 120 basis points of occupancy growth to 82% compared to the previous quarter [6] - The portfolio's weighted average remaining lease term was 5.4 years, with 51% of leases extending beyond February 2030 [8] Market Data and Key Metrics Changes - The real estate portfolio is valued at $488 million and consists of 1 million square feet primarily located in Manhattan, benefiting from a strong tenant base including large investment-grade firms [8][9] Company Strategy and Development Direction - The company is actively marketing 123 William Street and 196 Orchard for sale to unlock value and diversify holdings, with plans to use proceeds to retire debt and invest in higher-yielding assets [7] - The strategy to divest select Manhattan assets aims to reduce leverage and pursue more profitable ventures, enhancing shareholder value [10][13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the leasing pipeline and expects to close additional leasing and renewals in Q2 2025 [6] - The focus on resilient industries and transit-oriented locations is believed to position the portfolio well for maximizing shareholder value [10] Other Important Information - The company will hold its annual meeting of shareholders virtually on May 29, 2025 [4] Q&A Session Summary - No specific questions and answers were provided in the content.
United Insurance(ACIC) - 2025 Q1 - Earnings Call Transcript
2025-05-08 22:02
Financial Data and Key Metrics Changes - American Coastal Insurance reported a net income of $21.3 million, with core income at $20.7 million, a decrease of $3.7 million year-over-year due to increased policy acquisition costs [10] - The company achieved a combined ratio of 65%, aligning with its target, while the non-GAAP underlying combined ratio was 68.2% [10] - Cash and investments grew by 5.2% to $540.8 million, reflecting a strong liquidity position [11] - Stockholders' equity increased by 10.7% to $260.9 million, driven by first-quarter income, with book value per share rising to $5.4, a 10.4% increase from year-end 2024 [12] Business Line Data and Key Metrics Changes - Policies in force grew approximately 6% since year-end, with gross premiums written increasing by over 7% compared to the same period last year [4][10] - The underwriting environment for newer, well-maintained, low-rise, garden-style condos in Florida remains healthy and competitive, with the company open to new business [5] Market Data and Key Metrics Changes - The Florida condominium market is facing challenges related to declining affordability and resale values, but these issues are not significantly impacting the company's business [4][5] - The company is focused on maintaining competitive rates while managing risk, particularly in the Tri County area [19] Company Strategy and Development Direction - The company is increasing its internal quota share from 30% to 45%, which will feed more business to its captive, enhancing its balance sheet [39] - The company is cautiously expanding into the apartment building market, averaging about 15 policies per month, with an average premium of over $100,000 [28][29] - Management emphasizes a selective approach to growth in the apartment initiative, aiming for underwriting returns similar to those achieved in the condo segment [32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strong reserve position and the effectiveness of its catastrophe reinsurance program, which is expected to increase aggregate protection significantly [11][12] - The company is adopting a more conservative view of hurricane risk, leading to increased protection purchases this year [7] Other Important Information - The company reported a risk-adjusted reinsurance rate decrease of approximately 12%, consistent with the rate decreases shared with policyholders [9] - The company is currently finalizing a new top layer of its catastrophe reinsurance program, which is expected to enhance its coverage [6] Q&A Session Summary Question: Can you explain the rate trend and deductible chart? - Management clarified that the average account rate has been stable, with a decrease from record high levels, but remains healthy at approximately $0.97 as of March 31 [16][18] Question: What has changed regarding the reinsurance program? - Management noted a significant reduction in reinstatement costs from approximately $13 million last year to about $5 million this year, and improvements in coverage for third events [22][23][25] Question: How is the apartment building initiative progressing? - Management reported averaging about 15 policies per month in the apartment initiative, with a focus on maintaining underwriting standards and risk characteristics [28][30] Question: What are the plans for quota sharing going forward? - Management indicated satisfaction with the current quota share structure and mentioned the possibility of further reductions depending on reinsurance costs and availability [37][39] Question: Can you discuss the Amrisk management fee changes? - Management explained that a profit-sharing component was added to the Amrisk agreement, along with a 1% increase in the total percentage of fees, primarily passed on to producers [40][41]
Global Medical REIT(GMRE) - 2025 Q1 - Earnings Call Transcript
2025-05-08 14:00
Financial Data and Key Metrics Changes - At the end of Q1 2025, net income attributable to common shareholders was $2.1 million or $0.03 per share, compared to $800,000 or $0.01 per share in Q1 2024 [4][17] - FFO attributable to common shareholders and non-controlling interest was $14.8 million or $0.20 per share in Q1 2025, down from $14.9 million or $0.21 per share in Q1 2024 [5][17] - AFFO attributable to common stockholders and non-controlling interest was $16 million or $0.22 per share in Q1 2025, down from $16.5 million or $0.23 per share in Q1 2024 [5][17] - Total revenues decreased by approximately 1.4% to $34.6 million in Q1 2025 compared to the prior year quarter [14] Business Line Data and Key Metrics Changes - The portfolio occupancy rate was 95.6% with a weighted average lease term of 5.6 years and a rent coverage ratio of 4.4 times [4][14] - The company completed the acquisition of a five-property portfolio for $69.6 million at a 9% cap rate, with an aggregate annualized base rent of $6.3 million [5][9] Market Data and Key Metrics Changes - The company reported a gross investment in real estate of $1.5 billion, with total leasable square feet of 4.9 million [14][20] - The weighted average interest rate on total gross debt was 3.84% with a leverage ratio of 46.1% [21] Company Strategy and Development Direction - The company is focused on maintaining a high-quality diversified portfolio and is actively pursuing acquisition opportunities while remaining disciplined in its strategy [6][12] - The CEO succession plan is underway, with expectations to have a new CEO in place by June 30, 2025 [7][8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the current environment and highlighted the strong performance of the portfolio during economic downturns [22][70] - The company anticipates a full-year 2025 AFFO per share range of $0.89 to $0.93, assuming no additional acquisition or disposition activity beyond what has been completed or announced [21][22] Other Important Information - The company completed two property dispositions generating gross proceeds of $8.2 million, resulting in a gain of $1.4 million [13][17] - The company is monitoring the impact of tenant bankruptcies and expiring leases on occupancy rates, with expectations to retain 75% of expiring leases on a square foot basis for the full year 2025 [19][20] Q&A Session Summary Question: Timeline and expected rent collection for the East Orange facility - Management outlined the process of converting subtenants to direct tenants and expressed optimism about leasing activity, with expected net rents in the mid $13 to $15 range [25][29] Question: Impact of Prospect Medical on guidance - Management confirmed that the impact of Prospect Medical is factored into guidance but is not a significant component of the overall outlook [31] Question: Dividend sustainability and acquisition ability - Discussions regarding dividends are ongoing, with considerations for CapEx and strategic direction influencing decisions [45] Question: Retention rates and future expectations - Management noted that retention was lower than expected in Q1 but anticipates improvement as they work through expiring leases [48][49] Question: Leverage and acquisition opportunities - Management indicated a willingness to maintain leverage around current levels while pursuing acquisition opportunities that align with their strategy [57][58]
Hippo (HIPO) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:02
Financial Data and Key Metrics Changes - In Q1 2025, revenue grew 30% year over year to $110 million, up from $85 million in Q1 2024 [13] - Adjusted EBITDA loss was $41 million, a $21 million increase compared to Q1 2024, with $45 million of expenses related to the LA wildfires [16][17] - Net loss for Q1 was $48 million, a $12 million increase from Q1 2024, but would have improved by $33 million without the impact of the wildfires [16] Business Line Data and Key Metrics Changes - The Hippo homeowners insurance program saw a 35% year over year increase in gross written premium from homebuilder partners [7] - Insurance as a Service revenue grew 91% year over year to $39 million, driven by a 27% increase in gross earned premium [13] - HHIP revenue grew 12% year over year to $62 million, supported by improvements in reinsurance structure [14] Market Data and Key Metrics Changes - Written premium outside of HHIP increased 21% year over year, indicating diversification in business lines [9] - The HHIP gross loss ratio increased 41 percentage points year over year to 121%, primarily due to the LA wildfires [14][15] Company Strategy and Development Direction - The company is preparing to expand new business in the HHIP program after reducing written premium from existing homes in catastrophe-prone areas [8] - Plans to raise an additional $50 million in surplus notes to support growth in the Spinnaker platform, which has shown consistent profitability [10] - The company aims to generate net profit by the end of 2025, with a focus on revenue growth and improved underwriting performance [18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving net profit by Q4 2025, driven by higher premium retention and improved loss ratios [18] - The impact of the LA wildfires was acknowledged, but management emphasized that the new homes channel remained unaffected [12][16] - The company is optimistic about its long-term growth trajectory and plans to share a three-year roadmap at the upcoming Investor Day [11] Other Important Information - The company is focused on reducing fixed expenses through investments in infrastructure and automation, which will support future operating leverage improvements [10] - As of Q1, cash and investments decreased by $42 million to $528 million, primarily due to payments related to the LA fires [17] Q&A Session Summary Question: What will be the cost of the surplus note being raised? - The rate on the surplus note is approximately 9.5%, which is considered favorable for the company [23][24] Question: Will the capital from the surplus note fund the HHIP program or just Spinnaker? - The primary driver for raising the note is to fund the Spinnaker platform, but it will also support growth in the HHIP portfolio now that risks have been reduced [26][27] Question: How does the company view tariffs and their impact on new home sales? - The company can adjust coverage and premiums automatically at each renewal, ensuring adequate protection for policyholders despite material inflation [32][34] Question: When does the company expect to achieve EBITDA profitability? - The company is guiding for net income profitability in Q4 2025 and expects adjusted EBITDA to improve throughout the year [36][38] Question: Does the EBITDA loss include the assessment from the Fair Plan? - Yes, the $45 million loss includes the Fair Plan assessment, with $12 million attributed to Spinnaker non-HIPPO programs [39][41]
Hippo (HIPO) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:00
Financial Data and Key Metrics Changes - In Q1 2025, revenue grew 30% year over year to $110 million, up from $85 million in Q1 2024, driven primarily by the Insurance as a Service and HHIP Home Insurance Program segments [12] - The company expects to finish 2025 with an annual run rate of more than $500 million in revenue and generating net profit [11][18] - Q1 net loss was $48 million, a $12 million increase compared to Q1 2024, with $45 million of this loss related to the LA wildfires [15] - Adjusted EBITDA loss for Q1 was $41 million, a $21 million increase year over year, with the LA wildfires contributing $45 million to this loss [16] Business Line Data and Key Metrics Changes - The Hippo homeowners insurance program saw a 35% year-over-year increase in gross written premium from homebuilder partners [6] - Insurance as a Service revenue grew 91% year over year to $39 million, driven by a 27% increase in gross earned premium [12] - HHIP revenue grew 12% year over year to $62 million, supported by improvements in reinsurance structure [12][13] - Written premium outside of HHIP increased 21% year over year, contributing to diversification [7] Market Data and Key Metrics Changes - The company reported that new homes built to modern codes are more resilient, which has led to compelling underwriting results [6] - The HHIP gross loss ratio increased 41 percentage points year over year to 121%, primarily due to the LA wildfires [13] - The HHIP non-PCS loss ratio improved, declining six percentage points year over year to 53% due to portfolio transformation efforts [14] Company Strategy and Development Direction - The company is preparing to expand new business in the HHIP program after reducing written premium from existing homes in catastrophe-prone areas [6][10] - Investments in infrastructure and automation are aimed at reducing fixed expenses and improving operating leverage [9] - The company plans to share a three-year roadmap and long-term financial targets at the upcoming Investor Day on June 12, 2025 [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in generating net profit by Q4 2025, supported by revenue growth and improved premium retention [17] - The impact of the LA wildfires is expected to diminish as underwriting and pricing actions take effect throughout the year [17] - Management highlighted the importance of the Spinnaker platform for growth and risk participation [9][23] Other Important Information - The company is in the process of raising a $50 million surplus note to support growth in the Spinnaker platform, with an expected rate of approximately 9.5% [20][21] - Q1 ending cash and investments decreased by $42 million to $528 million, primarily due to payments related to the LA fires [16] Q&A Session Summary Question: What will be the cost of the surplus note? - The rate on the surplus note is approximately 9.5%, which is considered favorable for the company [20][21] Question: Will the capital from the note fund the HHIP program or just Spinnaker? - The primary driver for raising the note is to fund the Spinnaker side of the business, but it will also support growth in the HHIP portfolio [23][24] Question: How does the company view tariffs and their impact on new home sales? - The company can adjust coverage and premiums automatically at each renewal, ensuring adequate protection for policyholders despite tariff impacts [28][30] Question: When does the company expect to achieve EBITDA profitability? - The company is guiding for net income profitability in Q4 2025 and expects adjusted EBITDA to improve throughout the year [32][34] Question: Does the EBITDA loss include the assessment from the Fair Plan? - Yes, the $45 million loss includes the Fair Plan assessment, with $12 million attributed to Spinnaker non-EPO programs [35][36]
Mammoth Energy Services(TUSK) - 2025 Q1 - Earnings Call Transcript
2025-05-07 16:02
Financial Data and Key Metrics Changes - Total revenue for the first quarter of 2025 was $62,500,000, representing a 17% sequential increase from the fourth quarter of 2024 [12] - The net loss for the first quarter was $500,000, or a loss of $0.01 per diluted share, compared to a net loss of $15,500,000, or a loss of $0.32 per diluted share in the previous quarter [19] - Adjusted EBITDA was positive at $2,700,000 in the first quarter, compared to a negative $4,800,000 in the fourth quarter of 2024 [19] Business Line Data and Key Metrics Changes - Well Completions Services generated revenue of $20,900,000 with an average of 1.3 active pressure pumping fleets, up from $15,800,000 with 1.1 active fleets in the previous quarter [14] - The Sands segment sold approximately 189,000 tons of sand at an average price of $21.49 per ton, compared to 129,000 tons at $22.54 per ton in the fourth quarter [16] - Infrastructure Services revenue was $30,700,000 for the first quarter, a 10% sequential increase compared to the fourth quarter [17] Market Data and Key Metrics Changes - The company anticipates increased competition in gas basins due to strong fundamental support for natural gas, which may slightly squeeze margins in the near term [11] - There is uncertainty in the energy market stemming from tariffs, economic conditions, and geopolitical events, which have begun to affect oil prices [10] Company Strategy and Development Direction - The company is evaluating strategic opportunities to add accretive assets while maintaining a strong balance sheet [5] - Following the sale of three subsidiaries, the company will focus on engineering and fiber within the Infrastructure Services segment [17] - The company plans to strategically deploy capital to grow existing businesses that generate the greatest returns [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the team's ability to drive value for shareholders despite market uncertainties [9] - The company expects steady completions activity in 2025, with potential upside into 2026 driven by natural gas demand [14] - Management highlighted the importance of cost management and operational efficiency in navigating market challenges [22] Other Important Information - As of March 31, 2025, the company had unrestricted cash of approximately $56,700,000, with total liquidity of about $79,400,000 [21] - Following recent transactions, the company had unrestricted cash of $135,400,000 and total liquidity of $202,900,000 as of May 2, 2025 [21] Q&A Session Summary Question: Can you discuss the uplift in volumes in the sand business and your outlook for the rest of the year? - Management noted strong demand in Western Canada for sand pricing and expects a stable environment to persist through 2025 [26] Question: What cost actions could be taken if there is potential weakness in the back half of the year? - Management indicated that the biggest lever for cost management would be on staffing and repairs and maintenance, with a history of effectively managing the cost structure [28]
UFG(UFCS) - 2025 Q1 - Earnings Call Transcript
2025-05-07 16:02
Financial Data and Key Metrics Changes - Net written premium grew 4% to $335.4 million, although growth was impacted by unusual ceded reinsurance premium adjustments [8] - First quarter combined ratio was 99.4%, a 0.5 point increase from Q1 2024, while the underlying loss ratio improved 2.9 points to 56.5% [8][18] - Net investment income improved to $23.5 million, primarily due to an increase in fixed maturity income [10][21] - Reported book value per share improved to $32.13, with adjusted book value per share growing to $34.16 [11][24] Business Line Data and Key Metrics Changes - Net written premium in Core Commercial businesses grew 6% year-over-year, with renewal premium change remaining strong at 11.7% [14] - Rate achievement for general liability exceeded 9%, while automobile and umbrella lines produced double-digit rate changes [14][15] - Specialty and surety businesses performed in line with expectations, contributing to overall growth [16] Market Data and Key Metrics Changes - Catastrophe losses contributed five points to the combined ratio, including $8.2 million from California wildfires [10][19] - The company experienced a strong underwriting profit despite elevated industry catastrophe losses [20] Company Strategy and Development Direction - The company is in the final stages of developing a new policy administration system, which is expected to improve process efficiency and product management [12] - Focus remains on disciplined pricing, stable retention, and increased new business production across the portfolio [8][13] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to manage potential impacts from material and labor cost inflation through disciplined pricing and regular trend evaluations [26][27] - The company anticipates that the impact of additional ceded premium will diminish in the remaining quarters [13] Other Important Information - The first quarter expense ratio increased by three points to 37.9%, influenced by costs associated with the new policy administration system and elevated performance-based compensation for agents [10][23] - The company declared and paid a $0.16 per share cash dividend to shareholders [24] Q&A Session Summary Question: Current pricing power and ability to counter potential greater loss expenses - Management is closely monitoring the situation and believes that current rates exceed net loss trends, allowing for a cushion in estimates [26][27] Question: Underwriting expense ratio and levers to bring it down - The expense ratio was elevated due to one-time costs related to the new policy administration system, which is expected to normalize over time as the system is fully deployed [29][30][32] Question: Expectations for normalization of costs as the company grows - Management indicated that fixed costs provide leverage with premium growth, and the expense ratio is expected to normalize as agent performance returns to historical averages [33]
UWM Holdings Corporation (UWMC) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-05-06 15:57
Core Viewpoint - UWM Holdings Corporation is optimistic about its achievements in the first quarter of 2025 and plans to continue investing in technology to maintain a competitive edge in the mortgage industry [5]. Group 1: Company Overview - UWM Holdings Corporation held its first quarter 2025 earnings conference call, indicating a focus on financial performance and strategic direction [1][2]. - The call featured key participants including the Chief Business Officer, CEO, and CFO, highlighting the company's leadership engagement in discussing financial results [1][4]. Group 2: Financial Performance - The company is expected to provide insights into its financial results, including non-GAAP financial measures, which will be detailed in the earnings release [3].
CorMedix(CRMD) - 2025 Q1 - Earnings Call Transcript
2025-05-06 13:32
Financial Data and Key Metrics Changes - CorMedix reported first quarter net sales of $39.1 million, aligning with preannounced results, and achieved adjusted EBITDA of $23.6 million, slightly above earlier expectations [7][15] - The company recognized net income of $20.6 million or $0.32 per share, compared to a net loss of $14.5 million or $0.25 per share in the same quarter of the previous year [15] - Operating expenses increased approximately 9% to $17.4 million from $15.9 million year-over-year, with R&D expenses rising 281% to $3.2 million [16] Business Line Data and Key Metrics Changes - The majority of first quarter shipments (over 80%) came from U.S. Renal Care, with growth also noted in smaller outpatient dialysis operators and inpatient hospitals [31][32] - Inpatient hospital orders accounted for more than 6% of shipments in April, more than doubling from the first quarter [8] Market Data and Key Metrics Changes - The company anticipates net revenue guidance for DEFENCATH sales to existing customers in the first half of the year to be approximately $70 million, with a projected second quarter revenue of $23 million to $31 million [8] - The inpatient market is expected to grow as the dedicated sales team is now fully operational, and initial orders to VA facilities have been shipped [11] Company Strategy and Development Direction - CorMedix aims to expand DEFENCATH to new therapeutic indications and increase its customer base [18] - The company is optimistic about the implementation timeline with a large dialysis operator customer, targeting mid-year 2025 for the start [10] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the operational engagement with the large dialysis operator and noted that macro-level issues are not currently impacting inventory [25][26] - The company is focused on increasing utilization growth in the latter half of 2025 as new patients initiate therapy [10] Other Important Information - CorMedix has cash and cash equivalents of $77.5 million as of March 31, 2025, and expects cash operating expenses for 2025 to be between $72 million and $78 million [17] - The company is conducting a Phase 3 clinical study targeting the reduction of central line-associated bloodstream infections, with completion expected by late 2026 or early 2027 [12] Q&A Session Summary Question: Updates on the LDO partnership and operational engagement - Management noted increased preparatory activities with the large dialysis operator and remains cautiously optimistic about the timeline for implementation [22][23] Question: Drivers behind the first quarter revenue number - The majority of revenue was driven by U.S. Renal Care, with good growth also seen in smaller customers and hospitals [30][31] Question: Insights on U.S. Renal Care's patient pool and utilization tracking - Approximately 78% of first quarter revenue came from U.S. Renal Care, with good visibility into utilization versus inventory [42][43] Question: Reimbursement negotiations with Medicare Advantage - Management expects to enter negotiations with Medicare Advantage plans while TDAPA is still in force, with about 40% of claims currently from MA plans [44][46] Question: Inpatient segment opportunity and reimbursement process - The inpatient segment is expected to grow, but its overall percentage of business will depend on new customer onboarding and market dynamics [54][55]
iRadimed(IRMD) - 2025 Q1 - Earnings Call Transcript
2025-05-05 13:00
Financial Data and Key Metrics Changes - For Q1 2025, the company achieved revenue of $19.5 million, an 11% increase from $17.6 million in Q1 2024 [4][11] - Gross profit margin was reported at 76.1%, consistent with Q1 2024 [12] - GAAP diluted earnings per share increased by 16% to $0.37 from $0.32 in Q1 2024 [13] - Non-GAAP adjusted net income was $5.3 million or $0.42 per diluted share, up 17% from $4.6 million or $0.36 per diluted share in Q1 2024 [14] Business Line Data and Key Metrics Changes - Revenue from IV infusion pump systems grew 16% to $6 million, while disposable revenue increased 23% to $4.9 million [11][12] - Patient vital signs monitoring systems revenue remained steady at $6.5 million [12] - Domestic sales accounted for 82% of total revenue, up from 76% in Q1 2024, with domestic revenue increasing 19% to $16 million [12] Market Data and Key Metrics Changes - International sales declined 15% to $3.5 million [12] - Device revenue increased 9% to $13 million, driven by pump revenue and FMD systems [12] Company Strategy and Development Direction - The company is focused on increasing monitoring sales in 2025, anticipating a decline in pump revenues later in the year [21] - The new 3,870 MRIV pump is expected to be a revenue driver in 2026, with clearance anticipated in mid-2025 [9][10] - The company is nearing completion of a new facility, with full operations expected by July 2025 [10] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about the impact of tariffs, noting that only 3% of revenue is connected to high tariff sources [6][7] - The FDA's responsiveness has been positive, with ongoing interactions indicating progress towards device clearance [25][27] - The company expects Q2 2025 revenue guidance of $19.7 million to $19.9 million, reiterating full-year revenue guidance of $78 million to $82 million [10] Other Important Information - Operating expenses were $9.4 million, or 48% of revenue, down from 49% in Q1 2024 [12] - Cash flow from operations was $4.3 million, up 10% from $3.9 million in Q1 2024 [14] Q&A Session Summary Question: Any anomalies in disposable revenue growth? - Management indicated that some backlog was worked down in Q1, contributing to the growth, but expects future growth to align with capital growth [17][18] Question: Confidence in monitoring sales recovery? - Management emphasized efforts to boost monitoring sales through adjusted compensation structures, with strong bookings already seen in Q2 [20][22] Question: Status of FDA interactions and clearance timeline? - Management noted ongoing interactive questions from the FDA, suggesting a positive sign, with expectations for clarity in the next three to four weeks [24][27]